Oramed Pharmaceuticals Inc banner

Wall St Price Targets

OJU1 Price Forecast
Based on 3 analysts

+87% Upside
from €3.425 today

Oramed Pharmaceuticals Inc (OJU1)’s 12-month stock price forecast through November 2027 has a consensus target of €6.394, implying 87% upside. The forecast is based on price targets from 3 Wall Street analysts.

OJU1 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for OJU1 yet.

Oramed Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OJU1's stock price target?
Price Target
6.394 EUR

According to Wall Street analysts, the average 1-year price target for OJU1 is 6.394 EUR with a low forecast of 6.331 EUR and a high forecast of 6.582 EUR.

What is the Pre-Tax Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
236%

The compound annual growth rate for Pre-Tax Income over the next 1 year is 236%.

What is the Net Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
200%

The compound annual growth rate for Net Income over the next 1 year is 200%.

Back to Top